rs41305288
Variant names:
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Benign. The variant received -19 ACMG points: 1P and 20B. PP3BP4_StrongBP6_Very_StrongBS1BS2
The NM_001278064.2(GRM1):c.2185C>A(p.Pro729Thr) variant causes a missense change. The variant allele was found at a frequency of 0.0157 in 1,613,820 control chromosomes in the GnomAD database, including 263 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.013 ( 19 hom., cov: 32)
Exomes 𝑓: 0.016 ( 244 hom. )
Consequence
GRM1
NM_001278064.2 missense
NM_001278064.2 missense
Scores
9
5
4
Clinical Significance
Conservation
PhyloP100: 6.00
Publications
18 publications found
Genes affected
GRM1 (HGNC:4593): (glutamate metabotropic receptor 1) This gene encodes a metabotropic glutamate receptor that functions by activating phospholipase C. L-glutamate is the major excitatory neurotransmitter in the central nervous system and activates both ionotropic and metabotropic glutamate receptors. Glutamatergic neurotransmission is involved in most aspects of normal brain function and can be perturbed in many neuropathologic conditions. The canonical alpha isoform of the encoded protein is a disulfide-linked homodimer whose activity is mediated by a G-protein-coupled phosphatidylinositol-calcium second messenger system. This gene may be associated with many disease states, including schizophrenia, bipolar disorder, depression, and breast cancer. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, May 2013]
GRM1 Gene-Disease associations (from GenCC):
- spinocerebellar ataxia 44Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- autosomal recessive spinocerebellar ataxia 13Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, G2P
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -19 ACMG points.
PP3
Multiple lines of computational evidence support a deleterious effect 8: AlphaMissense, BayesDel_noAF, Cadd, Eigen, MutationAssessor, PROVEAN, REVEL, REVEL [when BayesDel_addAF, max_spliceai, FATHMM_MKL, MetaRNN, MutationTaster was below the threshold]
BP4
Computational evidence support a benign effect (MetaRNN=0.012637019).
BP6
Variant 6-146399224-C-A is Benign according to our data. Variant chr6-146399224-C-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 995109.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population sas. GnomAd4 allele frequency = 0.0128 (1948/152138) while in subpopulation SAS AF = 0.0227 (109/4808). AF 95% confidence interval is 0.0192. There are 19 homozygotes in GnomAd4. There are 1023 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 19 AR,AD gene
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0128 AC: 1944AN: 152020Hom.: 19 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
1944
AN:
152020
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.0165 AC: 4142AN: 251456 AF XY: 0.0178 show subpopulations
GnomAD2 exomes
AF:
AC:
4142
AN:
251456
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0160 AC: 23444AN: 1461682Hom.: 244 Cov.: 34 AF XY: 0.0163 AC XY: 11832AN XY: 727154 show subpopulations
GnomAD4 exome
AF:
AC:
23444
AN:
1461682
Hom.:
Cov.:
34
AF XY:
AC XY:
11832
AN XY:
727154
show subpopulations
African (AFR)
AF:
AC:
91
AN:
33476
American (AMR)
AF:
AC:
431
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
AC:
286
AN:
26136
East Asian (EAS)
AF:
AC:
3
AN:
39700
South Asian (SAS)
AF:
AC:
1969
AN:
86254
European-Finnish (FIN)
AF:
AC:
2176
AN:
53418
Middle Eastern (MID)
AF:
AC:
228
AN:
5768
European-Non Finnish (NFE)
AF:
AC:
17256
AN:
1111820
Other (OTH)
AF:
AC:
1004
AN:
60386
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.482
Heterozygous variant carriers
0
1459
2919
4378
5838
7297
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
644
1288
1932
2576
3220
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0128 AC: 1948AN: 152138Hom.: 19 Cov.: 32 AF XY: 0.0138 AC XY: 1023AN XY: 74356 show subpopulations
GnomAD4 genome
AF:
AC:
1948
AN:
152138
Hom.:
Cov.:
32
AF XY:
AC XY:
1023
AN XY:
74356
show subpopulations
African (AFR)
AF:
AC:
120
AN:
41500
American (AMR)
AF:
AC:
173
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
AC:
49
AN:
3468
East Asian (EAS)
AF:
AC:
1
AN:
5158
South Asian (SAS)
AF:
AC:
109
AN:
4808
European-Finnish (FIN)
AF:
AC:
337
AN:
10586
Middle Eastern (MID)
AF:
AC:
9
AN:
294
European-Non Finnish (NFE)
AF:
AC:
1098
AN:
68010
Other (OTH)
AF:
AC:
48
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.495
Heterozygous variant carriers
0
93
186
279
372
465
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
26
52
78
104
130
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
55
ALSPAC
AF:
AC:
37
ESP6500AA
AF:
AC:
6
ESP6500EA
AF:
AC:
132
ExAC
AF:
AC:
2089
Asia WGS
AF:
AC:
26
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:3
Jan 20, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
May 04, 2021
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
See Variant Classification Assertion Criteria. -
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
not specified Benign:1
Jan 09, 2024
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Benign
T
BayesDel_noAF
Pathogenic
DANN
Uncertain
DEOGEN2
Pathogenic
.;D;.;D;.
Eigen
Pathogenic
Eigen_PC
Pathogenic
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
.;D;D;.;D
MetaRNN
Benign
T;T;T;T;T
MetaSVM
Pathogenic
D
MutationAssessor
Pathogenic
M;M;M;M;M
PhyloP100
PrimateAI
Uncertain
T
PROVEAN
Pathogenic
D;D;D;D;D
REVEL
Pathogenic
Sift
Benign
D;D;D;D;D
Sift4G
Uncertain
T;D;T;D;T
Polyphen
D;D;.;D;D
Vest4
MPC
1.7
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.